Arizona Business and Health Summit 2024

The W. P. Carey School of Business at Arizona State University, in collaboration with Arizona Biomedical Research Centre, is hosting the third annual Arizona Business and Health Summit (ABHS). The summit will be a place for researchers, clinicians, practitioners, public policy makers, and community partners to advance business and health throughout Arizona through increased collaboration.

The conference is a not-to-be-missed event: A full day focusing on the discovery environment in Arizona for those conducting and using health- and business-related research.

Arizona Business and Health Summit Focus Areas for 2024

The 2024 Arizona Business and Health Summit explores factors impacting the goal of innovation for value in the health sector – essentially, greater benefits to patients at lower costs. Investment firms, entrepreneurs and biomedical sector companies are going through challenging times to meet the goal for healthcare provision in an environment of conflicting pressures. Demands emanating from the COVID-19 supply chain disruptions, a changing policy environment, resulting pressures from regulations, such as the Inflation Reduction Act of 2022, and continued cost escalation, test conventional strategies across the ecosystem of care delivery and its upstream resource-producing organizations.

Presenters will discuss strategies employed in the face of challenging healthcare reimbursement schemes, stakeholder expectations, and heightened concern for preparedness and resilience. Case studies of innovations for value will be presented and attendees will participate in roundtable discussions. These activities will be geared toward developing a framework to (1) influence value enhancement for the patient, for whom value is related to improved health, (2) influence value enhancement for investors who, depending on their role, seek a return on the capital transferred, (3) meet continued challenges associated with health maintenance/prevention, (4) consider clinician role in moving toward value, and (5) craft a population view of health.

Sessions during the day will prepare you to:

· Learn how the construct “value” is interpreted and motivates entities across the healthcare ecosystem to take action.

· Understand factors impacting innovation for value in the health sector.

· Understand how investors assess innovative products and processes and the likelihood for achieving success in the choice of strategies and their implementation.

· Become an orchestrator of change by recognizing the importance of innovators, clinicians, and providers partnering to inform needed innovation.

· Craft a framework for development plans to assure successful development and adoption of innovation.

Insights will be forthcoming from recognized experts in the field, including:

Cara Christ , M.D., MS. Dr. Christ oversees the Healthcare Quality Assurance (HQA) department at Blue Cross/Blue Shield of Arizona where she represents clinical and non-clinical teams aiming to make healthcare sustainable for our marketplace and enhance quality of care.

Denis Cortese, M.D. Dr. Cortese is Director, Health Care Delivery and Policy Program, Arizona State University and Emeritus President & Chief Executive Officer, Mayo Clinic.

Jim Eckler, M.S. Mr. Eckler is an ASU adjunct faculty member, Co-Founder of Healthcare Supply Chain Excellence and former Chief Operating Officer of Health Shared Services BC, the provider of shared services for the healthcare system across British Columbia.

Lara Ferry, Ph.D., Dr. Lara Ferry is the Vice President of Research for the Knowledge Enterprise, and a President’s Professor. In her administrative role, she is focused on research and strategic initiatives for for the University.

Ohad Kadan, Ph.D. Dr. Kadan is Dean of the W.P. Carey School of Business and holds the Charles J. Robel Dean Professor Of Finance And W. P. Carey Distinguished Chair.

Joan Koerber-Walker, President and CEO, Arizona Bioindustry Association, Inc., Ms. Koerber-Walker works on behalf of the Arizona Bioscience and Medical Technology Industry to support the growth of the industry, its members and community on the local and national level. Ms. Koerber-Walker is also a life science investor and has served on the boards of numerous for-profit and non-profit organizations.

Todd LaPorte, President and CEO, Honor Health. Mr. LaPorte has shaped a system with many access points to provide convenient, high quality care for patients, and with an ability to coordinate care efficiently and effectively. HonorHealth governs with its medical staff one of the country’s highest performing ACOs in the country.

Chuck Lehnn, President, Banner Health Network. Mr. Lehnn is responsible for developing accountable care solutions for Banner Health and its affiliated physicians. In his three decades at Banner, Lehn has served in such areas as corporate finance, rural health care administration, provider network development, managed care and health plan leadership.

Mike Long, President and CEO at Lumeris. – Mr. Long leads an organization with over $12 Billion in medical spend, dedicated to helping health systems and physician practices succeed in value-based care. Lumeris has been recognized for providing the highest quality, most cost-effective healthcare in the country.

Michael Nagel, President and CEO, Vomaris Wound Innovations. Vomaris harness the capacity of bioelectronics to develop solutions to support wound healing. Mr. Nagel has led the evolution of Vomaris introduction and marketing in both the acute care, outpatient and direct-to customer markets.

Adele Oliva, Co-founder of 1315 Capital in 2014. Ms. Oliva has been a healthcare investor for over 20 years and focuses on commercial stage medical technology, healthcare service, and specialty therapeutic investments to establish a firm focused on healthcare growth investing and the firm has $1 billion under management.

Mikaella Polyviou, Ph.D., Associate Professor and Co-Director, Supply Chain Resilience Initiative, W.P. Carey School of Business. She had carried out numerous studies on risk and resilience in supply chains.

David Roe, Chief Executive Officer. CortiCare. Mr. Roe leads CortiCare, a telehealth company that has helped redefne remote EEG monitoring in critical care and EMU and expanded the use of in-home ambulatory EEG.

Eugene Schnelller, Ph.D., Professor, Department of Supply Chain Management in the Department of Supply Chain Management at ASU. He serves as Interim Co-Executive Director of CAPS Research. Dr. Schneller is a national recognized authority in the area of health sector supply chain management.

Benjamin M. Shao, Ph.D. Is the Associate Dean for Asia-Pacific Programs and Initiatives, Professor of Information Systems, and the Co-Director of the Digital Society Initiative. His research areas cover IT impacts, data analytics, digital platforms, IS security, healthcare IT, and IS/OM interface. H

Jacque J. Sokolov, M.D. Chairman and Chief Executive Officer of the SSB, a diversified U.S. based healthcare management, development and investment company. Dr. Sokolov has a history of supporting value-based care with a focus on both provider organizations and clinicians.

Lars Thording, Ph.D., Vice President, Innovative Health LLC. He has been responsible for the launch of numerous market-disrupting solutions across healthcare, insurance and technology. Innovative Health is an advanced, FDA regulated reprocessing company focused on Electrophysiology devices.

Natalia Wilson, M.D., MP.H., Executive Director of the Center of Healthcare Delivery and Policy and an adjunct faculty member in the College of Health Solutions. Dr. Wilson’s research area is in implementation of unique device identifiers (UDI) in health systems.

Pre-Summit Reading:

It is suggested that attendees review the important World Economic Forum’s Insight report “Value in Healthcare: Laying the Foundation for Health System Transformation. https://www3.weforum.org/docs/WEF_Insight_Report_Value_Healthcare_Laying_Foundation.pdf

Preliminary Agenda

• Welcome and Background
• Advancing Vision for Value
• It Takes an Ecosystem of Innovation Focusing on Value
• Innovation for Patient Care Delivery
• Product Device Innovation
• Sustainability Innovation
• Innovation through Technology/Tele medicine
• A Biopharma Perspective
• A Payor’s Perspective
• Summary and Discussion
• Reception: End of day networking for all attendees

Organizing Committee

• Cristina Baciu, PhD, Assistant Director Research, W. P. Carey School of Business
• Phillip Barr, Assistant Director, Operations and Courses, Center Healthcare Delivery and Policy
• Denis A. Cortese, MD, Professor and Director, Center for Healthcare Delivery and Policy
• Jim Eckler, M.S., Visiting Professor, W. P. Carey Supply Chain Management
• Mikaella Polyviou, PhD, Assistant Professor, W.P. Carey Supply Chain Management
• Raghu Santanam, PhD, Senior Associate Dean for Executive Education, Corporate Partnerships and Lifelong Learning, McCord Chair in Business and Professor
• Eugene Schneller, PhD, Professor, W. P. Carey Supply Chain Management
• Jeffrey Wilson, PhD, Associate Dean of Research and Inclusive Excellence
• Natalia Wilson, MD MPH, Executive Director, Center for Healthcare Delivery and Policy, Adjunct Faculty College of Health Solutions

Thank you to the Arizona Biomedical Research Centre for their sponsorship of this event.